NYSE: AMN - AMN Healthcare Services

Yield per half year: -45.3%
Dividend yield: 0.00%
Sector: Healthcare

Company Analysis AMN Healthcare Services

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (23.32 $) is less than fair price (50.09 $)
  • The company's current efficiency (ROE=25.34%) is higher than the sector average (ROE=-82.41%)

Disadvantages

  • Dividends (0%) are below the sector average (1.31%).
  • The stock's return over the last year (-62.25%) is lower than the sector average (-33.71%).
  • Current debt level 44.89% has increased over 5 years from 31.95%.

Similar companies

Humana

UnitedHealth Group

Bristol-Myers

Johnson & Johnson

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

AMN Healthcare Services Healthcare Index
7 days -5.1% -1.2% 1.2%
90 days -0.3% -30% -5.2%
1 year -62.3% -33.7% 9.5%

AMN vs Sector: AMN Healthcare Services has significantly underperformed the "Healthcare" sector by -28.54% over the past year.

AMN vs Market: AMN Healthcare Services has significantly underperformed the market by -71.76% over the past year.

Stable price: AMN is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: AMN with weekly volatility of -1.2% over the past year.

3. Summary of the report

3.1. General

P/E: 13.97
P/S: 0.7765

3.2. Revenue

EPS 5.36
ROE 25.34%
ROA 7.2%
ROIC 22.41%
Ebitda margin 13.18%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (23.32 $) is lower than the fair price (50.09 $).

Price significantly below the fair price: The current price (23.32 $) is 114.8% lower than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (13.97) is lower than that of the sector as a whole (114.26).

P/E vs Market: The company's P/E (13.97) is lower than that of the market as a whole (73.05).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (3.54) is lower than that of the sector as a whole (9.02).

P/BV vs Market: The company's P/BV (3.54) is lower than that of the market as a whole (22.32).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (0.7765) is lower than that of the sector as a whole (4.1).

P/S vs Market: The company's P/S indicator (0.7765) is lower than that of the market as a whole (15.91).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (8.44) is lower than that of the sector as a whole (17.72).

EV/Ebitda vs Market: The company's EV/Ebitda (8.44) is lower than that of the market as a whole (23.05).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 39.35% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (39.35%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-50.52%).

5.4. ROE

ROE vs Sector: The company's ROE (25.34%) is higher than that of the sector as a whole (-82.41%).

ROE vs Market: The company's ROE (25.34%) is higher than that of the market as a whole (25.12%).

5.5. ROA

ROA vs Sector: The company's ROA (7.2%) is higher than that of the sector as a whole (6.75%).

ROA vs Market: The company's ROA (7.2%) is higher than that of the market as a whole (6.65%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (22.41%) is higher than that of the sector as a whole (15.68%).

ROIC vs Market: The company's ROIC (22.41%) is higher than that of the market as a whole (9.31%).

6. Finance

6.1. Assets and debt

Debt level: (44.89%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 31.95% to 44.89%.

Excess of debt: The debt is not covered by net income, percentage 623.07%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '1.31%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum AMN Healthcare Services

9.3. Comments